Massachusetts Society of Clinical Oncologists 2026 Meeting

Congratulations to Dr. Amalia Stavropoulos who will be presenting a poster, "KMT2C loss-of-function mutation is a BRCA1/2-independent determinant of PARP inhibitor sensitivity across various tumor types: a meta-analysis." at the upcoming MSCO 2026 meeting in Framingham, MA!